Par Drugs and Chemicals Limited — Important, 11-01-2025: General Updates

The Board of Directors has approved several strategic moves, including the slump sale of its existing establishment for ₹95 Crore, pending shareholder approval and expected to complete between September and December 2025. Additionally, the company plans to enter the clean and renewable energy, real estate, and capital markets sectors by altering its Memorandum of Association.

An Extra Ordinary General Meeting is scheduled for February 12, 2025, focusing on these initiatives, with specific e-voting dates set from February 9 to February 11, 2025. Leadership changes include the resignation of Whole Time Director Mr. Ghanshyam Savani, effective January 15, 2025, who will continue as Production Head. Non-Executive Director Mrs. Nayna Savani also resigned on the same date.

The board has decided to appoint Mrs. Bintal Shah to the Nomination and Remuneration Committee and Corporate Social Responsibility Committee following these changes. The company has also approved an increase in rooftop solar power generation capacity at its Bhavnagar facility, with further strategic exploration in emerging markets yielding a positive outlook.